Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TKI258 in Castration-Resistant Prostate Cancer
NCT00831792Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Apr 2010
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovitinib in prostate cancer (PCa), sponsored by University of Texas MD Anderson Cancer Center. Started Apr 2010; status: completed.
02
Drugs
dovitinib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00831792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00831792.